HLS Therapeutics Inc. (TSX:HLS)
Canada
· Delayed Price · Currency is CAD 4.340
+0.110 (2.60%)
Apr 28, 2025, 3:59 PM EDT
HLS Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -19.66 | -27.53 | -23.6 | -13.12 | -15.33 | Upgrade
|
| Depreciation & Amortization | 22.72 | 31.94 | 34.4 | 30.26 | 33.19 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.38 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 3.89 | 3.05 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.53 | 2.89 | -2.33 | -1.97 | -2.24 | Upgrade
|
| Stock-Based Compensation | 1.62 | -0.54 | 2.92 | 2.35 | 2.53 | Upgrade
|
| Other Operating Activities | 5.04 | 0.1 | 0.95 | 1.92 | -1.13 | Upgrade
|
| Change in Accounts Receivable | 2.36 | 0.63 | -0.07 | 1.04 | 1.52 | Upgrade
|
| Change in Inventory | -0.19 | -0.66 | -0.62 | 1.77 | -8.08 | Upgrade
|
| Change in Accounts Payable | -4.3 | 1.99 | 3.24 | -3.65 | -0.07 | Upgrade
|
| Change in Income Taxes | -0.11 | 0.39 | -0.29 | -0.45 | 0.2 | Upgrade
|
| Change in Other Net Operating Assets | 3.39 | 2.69 | -0.71 | -1.74 | -1.24 | Upgrade
|
| Operating Cash Flow | 8 | 15.79 | 16.94 | 16.43 | 9.34 | Upgrade
|
| Operating Cash Flow Growth | -49.31% | -6.81% | 3.12% | 75.82% | -64.62% | Upgrade
|
| Capital Expenditures | -0.02 | -0.04 | -0.05 | -0.05 | -0.04 | Upgrade
|
| Cash Acquisitions | -1.5 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | 13.25 | -0.15 | -10.1 | -4.46 | -44.64 | Upgrade
|
| Investing Cash Flow | 11.74 | -0.19 | -10.15 | -4.51 | -44.68 | Upgrade
|
| Long-Term Debt Issued | - | - | 10 | - | 20 | Upgrade
|
| Long-Term Debt Repaid | -21.57 | -9.46 | -10.44 | -11.14 | -6.66 | Upgrade
|
| Net Debt Issued (Repaid) | -21.57 | -9.46 | -0.44 | -11.14 | 13.34 | Upgrade
|
| Issuance of Common Stock | - | 0.13 | 0.18 | 4.91 | 1.64 | Upgrade
|
| Repurchase of Common Stock | -0.6 | -1.55 | -1 | -0.05 | - | Upgrade
|
| Common Dividends Paid | - | -2.4 | -4.96 | -5.12 | -4.75 | Upgrade
|
| Other Financing Activities | -1.19 | -1.36 | -0.64 | - | -0.66 | Upgrade
|
| Financing Cash Flow | -23.36 | -14.64 | -6.86 | -11.4 | 9.56 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.87 | 0.27 | -0.39 | 0.05 | -0.7 | Upgrade
|
| Net Cash Flow | -4.5 | 1.23 | -0.46 | 0.57 | -26.47 | Upgrade
|
| Free Cash Flow | 7.99 | 15.75 | 16.9 | 16.38 | 9.31 | Upgrade
|
| Free Cash Flow Growth | -49.28% | -6.80% | 3.14% | 76.00% | -64.48% | Upgrade
|
| Free Cash Flow Margin | 14.11% | 24.97% | 27.49% | 27.30% | 16.59% | Upgrade
|
| Free Cash Flow Per Share | 0.25 | 0.49 | 0.52 | 0.51 | 0.29 | Upgrade
|
| Cash Interest Paid | - | - | 6.51 | 6.17 | 5.13 | Upgrade
|
| Cash Income Tax Paid | 0.38 | 0.03 | 0.03 | 0.62 | 1.32 | Upgrade
|
| Levered Free Cash Flow | 26.39 | 24.71 | 15.63 | 12.13 | -45.33 | Upgrade
|
| Unlevered Free Cash Flow | 32.69 | 30.18 | 20.2 | 16.47 | -41.39 | Upgrade
|
| Change in Net Working Capital | 0.07 | -5.43 | -1.46 | 7.71 | 24.87 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.